Ono Pharmaceutical Co., Ltd.

Ono Pharmaceutical Co., Ltd.verified

OPHLF

Price:

$14.55

Market Cap:

$1.06T

Globally, Ono Pharmaceutical Co., Ltd., along with its affiliated entities, is engaged in the development, procurement, and commercialization of pharmaceutical products and diagnostic tools. Its product line features a wide array of therapeutic solutions, including several key oncology treatments such as OPDIVO, KYPROLIS, MEKTOVI, VELEXBRU, ADLUMIZ, and BRAFTOVI. It also offers EMEND and PROEMEND for managing chemotherapy-induced nausea and vomiting, and DEMSER for pheochromocytoma symptoms. For metabolic health, GLACTIV and FORXIGA target type 2 diabetes. The company provides medications for cardiovascular conditions (ONOACT for tachyarrhythmia, OPALMON for peripheral circulatory disorder, ...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2013-03-21

Stock Exchange

OTC

Ticker

OPHLF

The ROE as of June 2026 (TTM) for Ono Pharmaceutical Co., Ltd. (OPHLF) is 8.54%

According to Ono Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 8.54%. This represents a change of 297.01% compared to the average of 2.15% of the last 4 quarters.

Ono Pharmaceutical Co., Ltd. (OPHLF) Historical ROE (quarterly & annually)

How has OPHLF ROE performed in the past?

The mean historical ROE of Ono Pharmaceutical Co., Ltd. over the last ten years is 11.03%. The current 8.54% ROE has changed -22.61% with respect to the historical average. Over the past ten years (40 quarters), OPHLF's ROE was at its highest in in the September 2023 quarter at 5.49%. The ROE was at its lowest in in the March 2025 quarter at -0.84%.

Quarterly (TTM)
Annual

Average

11.03%

Median

10.68%

Minimum

6.40%

Maximum

16.14%

Ono Pharmaceutical Co., Ltd. (OPHLF) ROE by Quarter and Year

Discovering the peaks and valleys of Ono Pharmaceutical Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 102.83%

Maximum Annual ROE = 16.14%

Minimum Annual Increase = -60.37%

Minimum Annual ROE = 6.40%

Quarterly (TTM)
Annual
YearROEChange
20268.20%28.22%
20256.40%-60.37%
202416.14%6.22%
202315.19%23.78%
202212.28%3.21%
202111.89%12.06%
202010.61%14.79%
20199.25%-3.57%
20189.59%-10.78%
201710.75%102.83%

Ono Pharmaceutical Co., Ltd. (OPHLF) Average ROE

How has OPHLF ROE performed in the past?

The current ROE of Ono Pharmaceutical Co., Ltd. (OPHLF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

10.25%

5-year avg

11.64%

10-year avg

11.03%

Ono Pharmaceutical Co., Ltd. (OPHLF) ROE vs. Peers

How is OPHLF’s ROE compared to its peers?

Ono Pharmaceutical Co., Ltd.’s ROE is less than Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (7.70%), less than H. Lundbeck A/S (14.81%), less than Santen Pharmaceutical Co., Ltd. (13.15%), less than Hikma Pharmaceuticals PLC (15.83%), less than Hikma Pharmaceuticals PLC (15.83%), less than Kyowa Kirin Co., Ltd. (8.39%), less than H. Lundbeck A/S (14.81%), less than DiaSorin S.p.A. (11.98%), less than Fielmann AG (21.72%), less than Raia Drogasil S.A. (18.24%),

Build a custom stock screener for Ono Pharmaceutical Co., Ltd. (OPHLF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ono Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ono Pharmaceutical Co., Ltd. (OPHLF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ono Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Ono Pharmaceutical Co., Ltd.'s ROE?

How is the ROE calculated for Ono Pharmaceutical Co., Ltd. (OPHLF)?

What is the highest ROE for Ono Pharmaceutical Co., Ltd. (OPHLF)?

What is the 3-year average ROE for Ono Pharmaceutical Co., Ltd. (OPHLF)?

What is the 5-year average ROE for Ono Pharmaceutical Co., Ltd. (OPHLF)?

How does the current ROE for Ono Pharmaceutical Co., Ltd. (OPHLF) compare to its historical average?